Speakers

Expert Speaker Faculty

Take a look at the esteemed speaker faculty for the 9th MASH Drug Development Summit.

Belle Van Rosmalen

Director, Medical Development, Incretin Outcomes

Eli Lilly

Cynthia Arbeeny

Chief Scientific Officer

Mitotherapeutix

Cynthia Lebeaupin

Senior Scientist

Pfizer

Girish Rao

Executive Director, Clinical Design- Cardiometabolic Health, Clinical Design Delivery & Analytics

Eli Lilly

Hank Mansbach

Chief Medical Officer

89 Bio

Jen-Chieh Chuang

Director, Translational Biomarker Lead, Liver Diseases

Takeda Pharmaceuticals

Julio Gutierrez

Director, Medical

Altimmune

Kavita Juneja

Senior Director & Head of Metabolic Therapeutic Development

Corcept Therapeutics

Kevin Hart

Scientific Director

Pfizer

Kristin Fiorino

Director - Medical

AstraZeneca

Marie O’Farrell

Senior Vice President, Research & Development

Sagimet Biosciences

Oliver Yoa-Pu Hu

Scientific Board Member

Sinew Pharma

Patrice Mimche

Associate Professor

Indiana University

Rebecca Taub

Chief Executive Officer

Madrigal

Remi Laberge

Co-Founder & Chief Technology Officer

Arda Therapeutics

Reshma Shringarpure

Vice President, Clinical Research & Medical Affairs

Akero Therapeutics

Saheli Chowdhury

Postdoctoral Researcher

Columbia University

Sharon Jaycox

Director, Fatty Liver Disease

Global Liver Institute

Stanley Watowich

Founder & Chief Executive Officer

Ridgeline Therapeutics

Wen-Wei Tsai

Director

Sagimet Biosciences

Winston Dunn

Associate Professor

University of Kansas Medical Center

Zoltan Derdak

Medical Director, Early Clinical Development

Takeda Pharmaceuticals

Event Guide
Register
Partner